Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-47272Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-251646Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-293989Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-335078Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-346564Peak area normalizedfemale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-348554Peak area normalizedfemale normoglycemic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-414414Peak area normalizedmale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-458618Peak area normalizedmale diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-459906Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-538395Peak area normalizedfemale normoglycemic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-546238Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-609374Peak area normalizedmale pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-640282Peak area normalizedfemale diabetic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-692295Peak area normalizedmale pre-diabetic no neuropathy

Return to search page
  logo